Celgene Reports Second Quarter 2018 Operating and Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. SPY

Go back to Celgene Reports Second Quarter 2018 Operating and Financial Results

Celgene (CELG) PT Raised to $101 at SunTrust Robinson Humphrey

July 27, 2018 8:06 AM EDT

SunTrust Robinson Humphrey raised its price target on Celgene (NASDAQ: CELG) to $101.00 (from $96.00) while maintaining a Hold rating.

Analyst Yatin Suneja commented, "CELG reported 2Q sales above consensus on good performances from all core products except Otezla and Abraxane, while... More

Celgene (CELG) Tops Q2 EPS by 5c, Raises FY EPS Guidance

July 26, 2018 7:34 AM EDT

Celgene (NASDAQ: CELG) reported Q2 EPS of $2.16, $0.05 better than the analyst estimate of $2.11. Revenue for the quarter came in at $3.81 billion versus the consensus estimate of $3.7 billion.

GUIDANCE:

Celgene sees FY2018 EPS of $8.70-$8.75, versus the consensus of $8.52. Celgene sees... More